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Abstract
Background
Exposure to endogenous estrogen may protect against dementia, but evidence remains
equivocal. Such effects may be assessed more precisely in settings where exogenous
estrogen administration is rare. We aimed to determine whether reproductive period (men-
arche to menopause), and other indicators of endogenous estrogen exposure are inversely
associated with dementia incidence.
Methods
Population-based cohort studies of women aged 65 years and over in urban sites in Cuba,
Dominican Republic, Puerto Rico and Venezuela, and rural and urban sites in Peru, Mexico
and China. Sociodemographic and risk factor questionnaires were administered to all partic-
ipants, including ages at menarche, birth of first child, and menopause, and parity, with
ascertainment of incident 10/66 dementia, and mortality, three to five years later.
Results
9,428 women participated at baseline, with 72–98% responding by site. The ‘at risk’ cohort
comprised 8,466 dementia-free women. Mean age varied from 72.0 to 75.4 years, lower in
rural than urban sites and in China than in Latin America. Mean parity was 4.1 (2.4–7.2 by
site), generally higher in rural than urban sites. 6,854 women with baseline reproductive
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period data were followed up for 26,463 person years. There were 692 cases of incident
dementia, and 895 dementia free deaths. Pooled meta-analysed fixed effects, per year, for
reproductive period (Adjusted Sub-Hazard Ratio [ASHR] 1.001, 95% CI 0.988–1.015) did
not support any association with dementia incidence, with no evidence for effect modifica-
tion by APOE genotype. No association was observed between incident dementia and;
ages at menarche, birth of first child, and menopause: nulliparity; or index of cumulative
endogenous estrogen exposure. Greater parity was positively associated with incident
dementia (ASHR 1.030, 95% CI 1.002–1.059, I2 = 0.0%).
Conclusions
We found no evidence to support the theory that natural variation in cumulative exposure to
endogenous oestrogens across the reproductive period influences dementia incidence in
late life.
Introduction
Estrogen exerts potentially helpful effects on brain synapse structure and function in regions
such as the prefrontal cortex and hippocampus[1]. In women, endogenous estrogen exposure
(EEE) occurs mainly during the reproductive phase. Estrogen levels rise during pregnancy, but
fall postnatally, particularly with breastfeeding, and are lower after a first pregnancy than in
nulliparous women. Earlier menarche and later menopause (hence longer reproductive
period), nulliparity or lower parity, older age at birth of first child, and less breastfeeding are
therefore proxy indicators of lifetime EEE[2].
The hypothesis that estrogen is neuroprotective for women is supported by inverse associa-
tions between indicators of lifetime EEE and late-life cognitive function[2–7], and prospective
and historic cohort studies indicating adverse cognitive outcomes associated with premature
surgically-induced menopause[8], and premature ovarian failure (POF)[9]. However, the evi-
dence remains inconclusive. Only two studies of EEE were population-based, effects on cogni-
tion were small, and not always replicated[10]. Although effect sizes linked to oopherectomy
and POF are larger[8,9], associations with dementia were not replicated in a large Finland reg-
istry linkage study[11].
Few studies have examined the effects of EEE on cognitive decline, incident dementia or
Alzheimer’s disease (AD). In the population-based Esprit study in France, EEE indicators were
associated in the hypothesized direction with baseline cognitive function, but not with cogni-
tive decline over the next four years[4]. In case-control studies, childlessness was inversely
associated with AD among women but not men[12], and increasing numbers of pregnancies
were associated with AD, and age of onset among cases[13]. In a nested case-control study,
AD risk increased with increasing age at menarche[14]. The largest and most definitive study
to date was carried out in the population-based Rotterdam cohort; 3601 postmenopausal
women aged 55 years or older were followed up for a median of 6.3 years (21,046 person years)
[15]. Counter to the hypothesis, women with natural menopause and more reproductive years
had an increased risk of dementia (adjusted RR for highest versus lowest quarter 1.78, 95% CI
confidence interval [CI] 1.12–2.84). The association was modified by APOE genotype, with a
stronger association among APOE e4 carriers, while among non-carriers no association with
dementia or AD was observed.
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We set out to study associations between indicators of EEE and dementia incidence in the
10/66 Dementia Research Group’s population-based cohort studies in seven urban and three
rural catchment area sites in six Latin American countries, and China. Historically, these pop-
ulations were characterised by higher fertility rates, and a greater variation in age at first birth
and parity than in high income country populations. Contemporary market penetration data
suggest very low rates of use of hormone replacement therapy (exogenous estrogen)[16],
allowing the effects of EEE to be estimated more precisely. Our primary hypothesis is that a
longer reproductive period is independently associated with a lower risk of incident dementia.
Our secondary hypotheses are that younger age at menarche, older age at menopause, lower
parity, older age at birth of first child, and higher indices of cumulative endogenous estrogen
exposure (ICEEE), are each associated with a lower risk of incident dementia. Finally, we test
the hypothesis that APOE genotype modifies any effect of reproductive period on incident
dementia risk.
Materials and methods
The 10/66 population-based study protocols for baseline and incidence waves [17], and a full
description of the cohort profile [18] are available in open access publications. Relevant details
are provided here. One-phase population-based surveys were carried out of all residents aged
65 years and over in geographically defined catchment areas (urban sites in Cuba, Dominican
Republic, Puerto Rico and Venezuela, and urban and rural sites in Mexico, Peru, and China)
[17]. Baseline surveys were completed between 2003 and 2007, other than in Puerto Rico
(2007–2009). The target sample was 2000 for each country, and 3000 for Cuba. The baseline
survey included clinical and informant interviews, and physical examination. DNA collections
were carried out in the Latin American countries, and APOE genotype determined in Cuba,
Dominican Republic, Venezuela and Puerto Rico. Incidence waves were subsequently com-
pleted, with a mortality screen, between 2007 and 2011 (2011–2013 in Puerto Rico) aiming for
3–4 years follow-up in each site[19]. Assessments were identical to baseline protocols for
dementia ascertainment, and similar in other respects. We revisited participants’ residences on
up to five occasions. When no longer resident we sought information on their vital status and
current residence, from additional contacts recorded at baseline. Where participants had
moved away, we sought to re-interview them, even outside the catchment area. If deceased, we
recorded the date, and completed an informant verbal autopsy, including evidence of cognitive
and functional decline suggestive of dementia onset between baseline assessment and death
[20].
Measures
The 10/66 population-based study interview covers dementia diagnosis, mental disorders,
physical health, anthropometry, demographics, an extensive risk factor questionnaire, disabil-
ity, health service utilisation, care arrangements and strain[17]. Only relevant assessments are
detailed here.
Reproductive history measures: Evidence suggests that longer reproductive period (age at
menopause minus age at menarche), lower parity, older age at birth of first child, and greater
postmenopausal body mass are indicators of higher EEE across the life course [2,5]. Age at
menarche, age at menopause, number of live births, and age at birth of first child were ascer-
tained from all female participants at baseline interview, using four questions
1. How old were you when your periods began?
2. How many children did you have?
Reproductive period and dementia incidence in Latin America and China
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3. How old were you when your first child was born?
4. How old were you when you had the first symptoms of the menopause?
Weight was not measured at baseline, so waist circumference (in centimetres) was used as
the relevant proxy indicator instead. Following the method proposed by Smith et al[2] each
indicator was z-scored, and a composite Index of Cumulative Endogenous Estrogen Exposure
(ICEEE) calculated as ((age at menopause + age at birth of first child + waist circumference)–
(age at menarche + number of children).
Confounders and other covariates: Age, education, marital status, household assets, tobacco
consumption (ever versus never), and hazardous drinking (>21 units per week, before the age
of 65) were all ascertained in the baseline questionnaire. Height, leg length, skull circumfer-
ence and waist circumference were measured in the physical examination.
Dementia: 10/66 dementia diagnosis is allocated to those scoring above a cutpoint of pre-
dicted probability for dementia, calculated using coefficients from a logistic regression equa-
tion developed, calibrated and validated cross-culturally in the 25 centre 10/66 pilot study[21],
applied to outputs from a) a 25–40 minute structured clinical interview, the Geriatric Mental
State[22], assessing symptoms and signs of depression, anxiety and psychosis, as well as those
suggestive of organic brain disease including dementia, b) two cognitive tests; the 32-item
Community Screening Instrument for Dementia (CSI-D) COGSCORE[23], covering memory,
language, praxis, and executive function, and the modified Consortium to Establish a Registry
for Alzheimer’s Disease (CERAD) 10 word list learning task with delayed recall[24], and c)
informant reports of cognitive and functional decline from the 26-item CSI-D RELSCORE
[23]. Therefore, the assessment comprises a comprehensive clinical mental state assessment,
multidomain assessment of cognitive functioning, and an informant interview. The criterion,
concurrent and predictive validity of the 10/66 diagnosis were superior to that of the DSM-IV
criterion in subsequent evaluations[25–28]. For those who died between baseline and follow-
up we diagnosed ‘probable incident dementia’ by applying three criteria:
1. A score of more than two points on the RELSCORE, from the post-mortem informant
interview, with endorsement of either ‘deterioration in memory’ or ‘a general deterioration
in mental functioning’ or both, and
2. an increase in RELSCORE of more than two points from baseline, and
3. the onset of these signs noted more than six months prior to death.
In the baseline survey, the first criterion would have detected those with either DSM-IV or
10/66 dementia with 73% sensitivity and 92% specificity[20].
The prevalence[25] and incidence[20] of 10/66 dementia in the current cohorts have been
reported.
Analyses
We used release 2.0 of the 10/66 dementia incidence data archive (October 2015), and STATA
version 11 for all analyses.
For each site we
1. describe participants’ status at follow-up, age at menarche and menopause, and reproduc-
tive period for all those included in the cohort analysis (reinterviewed or deceased).
2. describe cohort characteristics by quarters of reproductive period, with tests for linear
trends (one-way ANOVA or Chi-squared tests for trend, as appropriate).
Reproductive period and dementia incidence in Latin America and China
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3. model the effect of ages at menarche, birth of first child, and menopause; reproductive
period; parity; ICEEE; and premature ovarian failure on 10/66 dementia incidence using a
competing-risks regression derived from Fine and Gray’s proportional subhazards model
[29] (Stata stcrreg command), based on a cumulative incidence function, indicating the
probability of failure (dementia onset) before a given time, acknowledging the possibility of
a competing event (dementia-free death). Time to death was the time from baseline inter-
view to the exact date of death. Time to dementia onset (which could not be ascertained
precisely) was the midpoint between baseline and follow-up interview. Competing risks
regression keeps those who experience competing events at risk so that they can be counted
as having no chance of failing. We report adjusted sub-hazard ratios (ASHR) with robust
95% confidence intervals adjusted for household clustering. We also test for modification
by APOE genotype of the effect of reproductive period on dementia incidence, by extend-
ing the adjusted models described above by the appropriate interaction terms, and also by
restricting the analysis to those with no APOE e4 genotype. We fit all models separately for
each site and combine them using a fixed effects meta-analysis. Higgins I2 estimates the
proportion of between-site variability in the estimates accounted for by heterogeneity, as
opposed to sampling error; up to 40% heterogeneity is conventionally considered negligible,
while up to 60% reflects moderate heterogeneity [30].
The study protocol and the consent procedures were approved by the King’s College Lon-
don research ethics committee and in all countries where the research was carried out: 1- Med-
ical Ethics Committee of Peking University the Sixth Hospital (Institute of Mental Health,
China); 2- the Memory Institute and Related Disorders (IMEDER) Ethics Committee (Peru);
3- Finlay Albarran Medical Faculty of Havana Medical University Ethical Committee (Cuba);
4- Hospital Universitario de Caracas Ethics Committee (Venezuela); 5- Consejo Nacional de
Bioe´tica y Salud (CONABIOS, Dominican Republic); 6- Instituto Nacional de Neurologı´a y
Neurocirugı´a Ethics Committee (Mexico); 7- University of Puerto Rico, Medical Sciences
Campus Institutional Review Board (IRB). Informed consent was documented in writing in all
cases. Literate participants signed their consent. For participants who were illiterate, the infor-
mation sheet was read to them in the presence of a literate independent witness, who attested
by signature that this process had been completed, and that the participant had provided
informed consent. For participants who lacked capacity to consent, agreement for their partic-
ipation was obtained from next-of-kin. These procedures were approved by the ethics
committees.
Results
Sample characteristics
In all, 9,428 interviews were completed with women, at baseline, in the 10 sites in seven coun-
tries. Response proportions at baseline varied between 72% and 98%, and exceeded 80% in all
sites other than urban China[25]. The ‘at risk’ cohort comprised 8,466 dementia-free women
(Table 1). Mean age at baseline ranged from 72.0 to 75.4 years, lower in rural than urban sites
and in China than in Latin America. Educational levels were lowest in rural China (84% not
completing primary education), rural Mexico (83%), Dominican Republic (73%), and urban
Mexico (57%) and highest in urban Peru (11%), Puerto Rico (23%), and Cuba (26%). In other
sites, between one-third and one-half of participants had not completed primary education.
Seven percent of women were nulliparous (from 0.4% in rural Peru to 14.6% in Cuba),
strongly associated with never having been married (34% of never married women and 5% of
married women were nulliparous). Mean parity was 4.1 (SD 3.0), higher in rural than urban
Reproductive period and dementia incidence in Latin America and China
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Table 1. Cohort flow, by site.
Site At risk
(n)
Status at follow up Age at menarche and menopause Reproductive period Outcome (menarche cohort
analysis)
Status Number
(%)
Menarche Mean
(SD)
Menopause Mean
(SD)
Mean (SD) Numbers in cohort analysis
(pyears)
Outcome Number
(%)
Cuba 1628 Interviewed 1249
(76.7%)
12.7 (1.8); MV = 7 48.0 (5.9); MV = 16 35.3 (6.1);
MV = 18
1473 (6028) Censored1 1101
(74.7%)
Deceased 255 (15.7%) Incident
dementia
127 (8.6%)
Lost 124 (7.6%) Competing risk2 245 (16.6%)
Dominican
Republic
1156 Interviewed 736 (63.7%) 13.6 (2.0);
MV = 37
46.3 (7.2); MV = 66 32.7 (7.3);
MV = 81
911 (3945) Censored1 620 (68.1%)
Deceased 212 (18.3%) Incident
dementia
113 (12.4%)
Lost 208 (18.0%) Competing risk2 178 (19.5%)
Puerto Rico 1183 Interviewed 818 (69.1%) 13.0 (1.9);
MV = 18
45.7 (7.3); MV = 29 32.8 (7.5);
MV = 37
905 (3686) Censored1 712 (78.7%)
Deceased 118 (10.0%) Incident
dementia
97 (10.7%)
Lost 247 (20.9%) Competing risk2 96 (10.6%)
Peru Urban 802 Interviewed 540 (67.3%) 12.9 (1.7);
MV = 15
45.7 (6.1); MV = 17 32.9 (6.0);
MV = 25
548 (1544) Censored1 496 (90.5%)
Deceased 26 (3.2%) Incident
dementia
27 (4.9%)
Lost 236 (29.5%) Competing risk2 25 (4.6%)
Peru Rural 271 Interviewed 211 (77.9%) 13.0 (1.8); MV = 7 46.6 (5.9); MV = 15 33.6 (6.0);
MV = 17
221 (757) Censored1 185 (83.7%)
Deceased 19 (7.0%) Incident
dementia
19 (8.6%)
Lost 41 (15.1%) Competing risk2 17 (7.7%)
Venezuela 1150 Interviewed 769 (66.9%) 13.1 (1.6); MV = 5 48.5 (5.6); MV = 50 35.4 (5.7);
MV = 51
844 (3339) Censored1 674 (79.9%)
Deceased 80 (7.0%) Incident
dementia
101 (12.0%)
Lost 301 (26.1%) Competing risk2 69 (8.2%)
Mexico Urban 597 Interviewed 460 (77.1%) 13.4 (1.6);
MV = 10
47.1 (5.9); MV = 27 33.7 (6.2);
MV = 30
494 (1430) Censored1 423 (85.6%)
Deceased 44 (7.4%) Incident
dementia
32 (6.5%)
Lost 93 (15.5%) Competing risk2 39 (7.9%)
Mexico Rural 547 Interviewed 411 (75.1%) 14.0 (1.5);
MV = 20
45.6 (5.6); MV = 30 31.6 (5.7);
MV = 40
439 (1221) Censored1 350 (79.7%)
Deceased 48 (8.8%) Incident
dementia
46 (10.5%)
Lost 88 (16.1%) Competing risk2 43 (9.8%)
China Urban 609 Interviewed 419 (68.8%) 14.8 (1.7); MV = 0 48.2 (3.4); MV = 0 33.5 (3.8);
MV = 0
496 (2252) Censored1 368 (74.2%)
Deceased 77 (12.6%) Incident
dementia
62 (12.5%)
Lost 113 (19.6%) Competing risk2 66 (13.3%)
China Rural 523 Interviewed 394 (75.3%) 15.3 (1.2); MV = 0 50.3 (2.5); MV = 2 35.0 (2.8);
MV = 2
523 (2263) Censored1 338 (64.6%)
Deceased 129 (24.7%) Incident
dementia
68 (13.0%)
Lost 0 (0.0%) Competing risk2 117 (22.4%)
Total 8466 Interviewed 6007
(71.0%)
13.4 (1.9);
MV = 119
47.3 (6.1); MV = 252 33.9 (6.2);
MV = 301
6854 (26463) Censored1 5267
(76.8%)
Deceased 1008
(11.9%)
Incident
dementia
692 (10.1%)
Lost 1451
(17.1%)
Competing risk2 895 (13.1%)
1Censored refers to those participants who survived to follow-up interview and were dementia-free.
2Competing risk refers to ‘dementia-free death’, that is those participants who had died before they could be reinterviewed, but for whom there was no evidence from
informant verbal autopsy interview of their having developed probable dementia before death.
https://doi.org/10.1371/journal.pone.0192889.t001
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sites and ranging from 2.4 (urban Cuba) to 7.2 (rural Mexico). There was significant between
site variation in ages at menarche and menopause, and reproductive period. Menarche (R2 =
15.7%) was earlier in Latin American and urban sites. Menopause (R2 = 4.6%) was later in Chi-
nese sites. Reproductive period (R2 = 1.6%) showed no clear pattern of variation among sites.
From the ‘at risk’ cohort, 1,451 participants (17.1%) were lost to follow-up; 473 (5.6%) had
refused, 387 (4.6%) were traced but could not be contacted for interview, 336 (4.0%) could not
be traced, and for 225 (3.0%) the reason for loss to follow-up was not documented (Table 1).
This left 7,015 women eligible to be included in the cohort, of whom 6,007 were reinterviewed,
and 1,008 had died and an informant verbal autopsy was completed. Of these, 6,854 women
had baseline reproductive period data, and were followed up for 26,463 person years (Table 1).
In the at risk cohort, longer reproductive period was associated, predictably, with earlier
menarche and (particularly) later menopause, and with a higher ICEEE (Table 2). Longer
reproductive period was also associated with older age; with being more likely to complete pri-
mary education; with lower parity; with older age at birth of first child; with a lower prevalence
of hazardous drinking and stroke; with taller stature, and with better baseline cognitive func-
tion (the composite CSI-D COGSCORE, and the CERAD animal naming test, but not the
CERAD 10 word list delayed recall). The effect on COGSCORE (effect size per quarter of
reproductive period +0.064, 95% CI +0.021 to +0.107, r2 = 0.1%) was no longer statistically sig-
nificant having adjusted for age, education, marital status, stroke, hazardous alcohol use, and
height (+0.024, 95% CI -0.019 to +0.067, r2 = 0.0%). The effect on animal naming (+0.195,
95% CI +0.094 to +0.295, r2 = 0.2%) also lost statistical significance after adjusting for the same
covariates (+0.092, 95% CI -0.006 to +0.190, r2 = 0.0%). Although the proportion with one or
more APOE e4 alleles did decline significantly across quarters of reproductive period
(p = 0.048, Table 2), neither mean reproductive period (p = 0.08), nor mean age at menarche
(p = 0.38), nor mean age at menopause (p = 0.17) differed significantly across APOE
genotypes.
Primary hypothesis—Reproductive period and incident dementia
Controlling for age, education and household assets, there was no association between repro-
ductive period and dementia incidence, either in individual sites or after pooled metaanalysis
(ASHR per year 1.001, 95% CI 0.988–1.015, I2 0.0%) (Table 3). The effect of reproductive
period was unchanged after controlling additionally for marital status, hazardous alcohol use,
stroke, and height (ASHR per year 1.001, 95% CI 0.987–1.015, I2 0.0%). In Cuba, Dominican
Republic, Venezuela and Puerto Rico, where APOE genotype was available, there was no evi-
dence for an interaction between APOE genotype and reproductive period (ASHR 0.993, 95%
CI 0.947–1.041, I2 = 39.3%), or for an effect of reproductive period among non-carriers of the
e4 allele (ASHR 1.012, 95% CI 0.991–1.034, I2 = 0.0%). Controlling for APOE genotype in
addition to age, education, household assets, marital status, hazardous alcohol use, stroke and
height did not affect the fully adjusted association between reproductive period and incident
dementia (ASHR 1.018, 95% CI 0.998–1.038, I2 = 0.0%).
Secondary hypotheses
Controlling for age, education and household assets, there was no association between demen-
tia incidence and either age at menarche (pooled ASHR per year 0.986, 95% CI 0.944–1.030, I2
0.0%), or age at menopause (ASHR per year 1.000, 95% CI 0.986–1.013, I2 0.0%) (Table 3).
There was also no association between premature ovarian failure (before the age of 40 years)
and incident dementia (ASHR 1.19, 95% CI 0.91–1.55, I2 0.0%). However, as hypothesized,
greater parity was associated with incident dementia, controlling for marital status as well as
Reproductive period and dementia incidence in Latin America and China
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age, education and assets (ASHR per birth 1.030, 95% CI 1.002–1.059, I2 0.0%). The effect of
nulliparity, a rare exposure, was difficult to estimate with no exposed incident cases in urban
and rural Peru or rural China; in the remaining sites there was no association (ASHR 1.16,
95% CI 0.86–1.56, I2 30.2%). Neither was there any evidence for an association between the
ICEEE and incident dementia (ASHR per SD 0.987, 95% CI 0.951–1.025, I2 0.0%).
Discussion
In the largest prospective cohort study to date we have found quite strong evidence that EEE is
not importantly associated with subsequent risk of incident dementia. We also failed to repli-
cate a previously reported interaction between APOE genotype and reproductive period. The
precision of our null estimates for the hypothesised main effects of proxy indicators of EEE,
observed consistently across diverse settings, exclude the possibility of other than trivial effects.
The possible exception is premature ovarian failure, a rare exposure, with an upper confidence
interval for the ASHR of 1.55, and with suggestive trends towards positive associations in
some Latin American sites. While we did observe an association between greater parity and
incident dementia, this seems unlikely to be mechanistically explained by cumulative EEE,
since the impact of reproductive period on this pathway would be expected to be much greater.
Of note, grand multiparity is linked to increased mortality from both diabetes and cardiovas-
cular diseases[31].
Table 2. Cohort characteristics at baseline, by quarters of reproductive period.
Reproductive period (range in
years) (MV = 366)
1st quarter (<31)
n = 2050
2nd quarter (31–34)
n = 1827
3rd quarter (35–37)
n = 1948
4th quarter (>38)
n = 2275
All combined
n = 8466
Test for linear
trend
Mean age in years (SD) 73.5 (6.5) 73.4 (6.4) 73.8 (6.7) 73.9 (6.9) 73.8 (6.7) 5.8, 0.02
Did not complete primary education
(%)
872 (42.6%) 825 (44.2%) 897 (46.0%) 803 (35.4%) 2613 (42.8%) 18.5, <0.001
Mean age at menarche 13.7 (2.1) 13.7 (1.9) 13.7 (1.5) 12.6 (1.7) 13.4 (1.9) 394.2, <0.001
Mean age at menopause 39.2 (4.6) 46.4 (2.2) 49.6 (1.6) 53.1 (2.9) 47.3 (6.1) 22652.8, <0.001
Mean age at birth of first child 22.0 (4.9) 22.3 (4.6) 22.4 (5.1) 22.6 (5.4) 22.3 (5.0) 8.4, 0.004
Nulliparous (%) 173 (8.6%) 103 (5.7%) 103 (5.4%) 159 (7.1%) 576 (6.9%) 3.5, 0.06
Mean live births (SD) 4.2 (3.1) 4.2 (2.9) 4.1 (2.9) 3.9 (2.9) 4.1 (3.0) 14.7, <0.001
Index of estrogen exposure
(n = 6504)
-1.66 (2.13) -0.44 (1.90) +0.24 (1.99) +1.59 (2.16) -0.01 (2.38) 2194.6, <0.001
Ever smoked (%) 489 (23.9%) 386 (21.2%) 374 (19.3%) 567 (25.0%) 1907 (22.6%) 0.3, 0.59
Hazardous drinker (%) 78 (4.0%) 41 (2.4%) 31 (1.7%) 51 (2.5%) 219 (2.8%) 10.1, 0.002
Stroke (%) 136 (6.6%) 104 (5.7%) 84 (4.3%) 122 (5.4%) 464 (5.5%) 5.0, 0.03
Diabetes (%) 398 (19.5%) 337 (18.4%) 325 (16.7%) 443 (19.5%) 1571 (18.6%) 0.1, 0.76
Obesity (%) 1145 (59.3%) 959 (54.9%) 965 (52.2%) 1283 (60.9%) 4352 (57.0%) 0.4, 0.53
Mean height in centimetres 153.0 (7.5) 153.3 (7.2) 154.1 (7.3) 153.9 (7.3) 153.5 (7.4) 20.6, <0.001
Mean leg length in centimetres 85.1 (6.9) 84.8 (6.9) 84.4 (7.9) 85.5 (7.1) 84.9 (7.2) 1.7, 0.18
Mean skull circumference in
centimetres
54.9 (2.1) 54.8 (2.2) 54.9 (2.2) 54.8 (2.3) 54.8 (2.2) 0.0, 0.90
Mean CSI-D COGSCORE 30.2 (2.3) 30.3 (2.3) 30.3 (2.4) 30.4 (2.2) 30.2 (2.4) 8.4, 0.004
Mean CERAD 10 word recall 4.9 (2.1) 5.0 (2.1) 4.8 (2.0) 5.0 (2.0) 4.9 (2.0) 0.2, 0.64
Mean CERAD animal naming 15.4 (5.1) 15.5 (5.1) 15.4 (5.3) 16.0 (5.6) 15.5 (5.3) 14.4, <0.001
One or more APOE e4 alleles1 (%) 188 (22.3%) 111 (18.5%) 151 (20.1%) 224 (18.2%) 709 (19.9%) 3.9, 0.05
1This analysis was conducted using data from the four sites where APOE genotype was available; Cuba (n = 1427), Dominican Republic (n = 635), Venezuela (n = 599),
and Puerto Rico (n = 907), total (n = 3568).
https://doi.org/10.1371/journal.pone.0192889.t002
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In common with some other studies, we did find evidence for an association between
reproductive period and baseline cognitive function, somewhat stronger for animal naming
than for the CSI-D composite assessment of cognitive function. However, consistent with
other studies the effect sizes were very small, and, in our study, were substantially accounted
for by plausible confounders.
Strengths and weaknesses of the study
Strengths of this study are that associations have been assessed longitudinally, in large popula-
tion-based dementia-free cohorts, encompassing rural and urban catchment area sites in the
Caribbean, Latin America, and China. We used meta-analytical techniques to increase the pre-
cision of our estimates. Fixed effect meta-analysis is appropriate, given the negligible heteroge-
neity for all of the associations studied.
We acknowledge some limitations. First there will have been some misclassification of the
recalled exposures, which, given the prospective design, is likely to have been non-differential
with respect to the outcome. The effect would therefore be towards an attenuation of any genu-
ine association towards the null. Second, we did not gather information on use of hormone
Table 3. Associations between indicators of endogenous estrogen exposure and incident dementia (adjusted1 subhazard ratios with 95% confidence intervals).
Site Age at
Menarche (per
year)
Age at
menopause (per
year)
Reproductive
period (per year)
Parity (per
child)2
Nulliparity2 Age at birth
of first child
Index of endogenous
estrogen exposure3
(per SD)
Premature
ovarian failure4
Cuba 1.005 (0.916–
1.101)
0.998 (0.968–
1.030)
0.998 (0.968–
1.029)
0.98 (0.89–
1.08)
1.07 (0.66–1.73) 1.008 (0.975–
1.042)
1.012 (0.925–1.108) 1.07 (0.57–2.00)
Dominican
Republic
0.958 (0.863–
1.063)
0.996 (0.965–
1.029)
1.000 (0.968–
1.034)
1.05 (1.00–
1.10)
0.66 (0.31–1.41) 0.973 (0.934–
1.015)
0.967 (0.874–1.069) 1.53 (0.92–2.53)
Peru urban 0.959 (0.733–
1.255)
0.986 (0.935–
1.041)
0.988 (0.932–
1.048)
1.12 (0.99–
1.26)
Not estimated5 0.963 (0.855–
1.084)
0.882 (0.744–1.047) 1.16 (0.39–3.42)
Peru rural 1.062 (0.772–
1.462)
1.050 (0.926–
1.189)
1.040 (0.928–
1.166)
1.09 (0.92–
1.29)
Not estimated6 0.996 (0.904–
1.098)
0.953 (0.768–1.182) 1.58 (0.44–5.72)
Venezuela 0.924 (0.820–
1.042)
0.976 (0.940–
1.014)
0.984 (0.946–
1.024)
1.04 (0.97–
1.12)
0.34 (0.05–2.35) 0.977 (0.939–
1.015)
0.975 (0.906–1.049) 1.40 (0.63–3.08)
Mexico urban 1.105 (0.903–
1.353)
1.007 (0.939–
1.079)
0.999 (0.935–
1.068)
1.02 (0.93–
1.11)
0.61 (0.15–2.56) 1.021 (0.943–
1.106)
0.967 (0.828–1.130) 2.47 (0.82–7.51)
Mexico rural 1.070 (0.902–
1.269)
1.021 (0.970–
1.075)
1.010 (0.963–
1.059)
1.00 (0.91–
1.09)
1.92 (0.57–6.47) 1.075 (1.005–
1.149)
1.082 (0.931–1.257) 0.94 (0.32–2.75)
China urban 0.967 (0.826–
1.132)
0.996 (0.932–
1.065)
1.004 (0.947–
1.064)
0.95 (0.82–
1.11)
2.43 (1.02–5.76) 1.005 (0.950–
1.064)
1.063 (0.924–1.223) Not estimated5
China rural 0.908 (0.731–
1.127)
1.008 (0.909–
1.118)
1.030 (0.923–
1.149)
0.98 (0.84–
1.14)
Not estimated5 1.013 (0.889–
1.155)
1.114 (0.845–1.469) Not estimated5
Puerto Rico 1.001 (0.904–
1.108)
1.009 (0.983–
1.036)
1.007 (0.981–
1.033)
1.03 (0.96–
1.11)
1.48 (0.79–2.77) 0.970 (0.927–
1.015)
0.959 (0.866–1.062) 0.64 (0.34–1.20)
Pooled fixed
effect
0.986 (0.944–
1.030), I2 =
0.0%
1.000 (0.986–
1.013), I2 = 0.0%
1.001 (0.988–
1.015), I2 = 0.0%
1.030 (1.002–
1.059), I2 =
0.0%
1.16 (0.86–1.56),
I2 = 30.2%
0.994 (0.978–
1.011), I2 =
7.3%
0.987 (0.951–1.025), I2
= 0.0%
1.19 (0.91–
1.55), I2 = 0.0%
1Controlling for age, education and assets.
2Controlling for age, education, assets, and marital status.
3derived from (age at menopause + waist circumference)–(age at menarche + number of live births + age at first birth), all indicators having first been standardised as z-
scores.
4defined as age at menopause < 40 years.
5No incident cases exposed.
6No cohort participants exposed.
https://doi.org/10.1371/journal.pone.0192889.t003
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replacement therapy (exogenous estrogen). However, availability, awareness and use of such
medication can be safely assumed to have been negligible in these countries over the relevant
period [16,32–34], particularly in the predominately socio-economically disadvantaged catch-
ment area populations studied. Nevertheless, we cannot exclude the possibility that use of
exogenous estrogen could have masked associations with proxy indicators for EEE, particu-
larly if this was used selectively by those experiencing earlier menopause. Third, we did not
enquire whether menopause was surgically induced or naturally occurring. Oopherectomy,
because of the sudden fall in estrogen levels, might have a particularly marked impact on cog-
nitive functioning[8]. Fourth, it is likely that reproductive history predicts post-reproductive
mortality, with a higher mortality risk for those with younger age at first birth, and a U-shaped
relationship with parity [35]. To the extent that such associations might selectively remove
those who might be at risk for developing dementia from the at risk population, this could bias
estimates of association. This possibility is addressed, in part, through our use of competing
risk regression to model associations, but this would only account for selective mortality pat-
terns over the follow-up period.
Contextualisation with other research
The only previous longitudinal study of these associations was in a smaller and younger cohort
from Rotterdam (167 incident dementia cases, compared with 692 in our study)[15]. The
greater power and precision of our study may not entirely explain the discrepancy in findings;
the Dutch study reported a statistically significant increased risk of dementia concentrated in
the three-quarters of the cohort with the longest reproductive periods, but only for non-carri-
ers of the APOE e4 genotype. Although the distribution of reproductive periods was similar
between the two cohorts, the reproductive history of the Dutch women was very different.
Mean parity was 2.2 compared with 4.1 in our study, 11% reported ever using HRT, and 24%
reported an artificial menopause from surgery, drugs or radiation therapy.
Conclusions
We found no evidence to support the theory that natural variation in cumulative exposure to
endogenous estrogens across the reproductive period influences the incidence of dementia in
late life. Any beneficial effect on cognitive reserve is likely to be very small, and may arise from
confounding by shared developmental antecedents. The case for post-menopausal hormone
replacement is currently controversial, with conflicting evidence, and some clear risks associ-
ated with longer-term use[36]. Nevertheless, the concept of a ‘critical window’ in the immedi-
ate post-menopausal period has been widely discussed, during which estrogen replacement
therapy may be both less risky, and more beneficial to cognition[8,36,37]. Our study provides
only indirect evidence to inform this debate, since our focus was upon pre-menopausal endog-
enous exposure. However, associations with indicators of endogenous exposure are routinely
presented as ‘proof of concept’ for the estrogen hypothesis, and this evidence is significantly
weakened by the current study.
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